We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$20.8B
AUM Growth
+$603M
Cap. Flow
-$923M
Cap. Flow %
-4.43%
Top 10 Hldgs %
30.46%
Holding
770
New
97
Increased
229
Reduced
280
Closed
93

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$125M
2
V icon
Visa
V
+$87.5M
3
DAR icon
Darling Ingredients
DAR
+$66M
4
CONE
CyrusOne Inc Common Stock
CONE
+$55M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$52.4M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$219M
2
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$129M
3
VER
VEREIT, Inc.
VER
+$121M
4
KSU
Kansas City Southern
KSU
+$96.9M
5
MSFT icon
Microsoft
MSFT
+$94.2M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 18.61%
3 Financials 13.52%
4 Communication Services 8.13%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.03B 4.95%
3,064,927
-290,564
-9% -$94.2M
AAPL icon
2
Apple
AAPL
$4.72T
$774M 3.72%
4,358,047
-114,250
-3% -$18.1M
UNH icon
3
UnitedHealth
UNH
$385B
$769M 3.69%
1,530,765
-15,541
-1% -$7.03M
KO icon
4
Coca-Cola
KO
$349B
$568M 2.73%
9,592,456
-68,992
-0.7% -$3.84M
USB icon
5
US Bancorp
USB
$98.7B
$560M 2.69%
9,961,471
+131,308
+1% +$7.77M
ACN icon
6
Accenture
ACN
$84.9B
$542M 2.6%
1,307,413
-128,388
-9% -$46.8M
ORCL icon
7
Oracle
ORCL
$346B
$533M 2.56%
6,112,650
-719,612
-11% -$67.6M
WFC icon
8
Wells Fargo
WFC
$261B
$526M 2.53%
10,967,845
+186,092
+2% +$9.16M
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$3.89T
$523M 2.51%
3,611,060
-109,060
-3% -$15.7M
LRCX icon
10
Lam Research
LRCX
$400B
$518M 2.49%
7,196,410
+94,620
+1% +$5.93M
ELV icon
11
Elevance Health
ELV
$82.3B
$511M 2.45%
1,102,028
-39,818
-3% -$16.8M
JNJ icon
12
Johnson & Johnson
JNJ
$624B
$437M 2.1%
2,555,669
+34,890
+1% +$5.71M
META icon
13
Meta Platforms (Facebook)
META
$1.54T
$402M 1.93%
1,196,449
-143,110
-11% -$47.5M
TJX icon
14
TJX Companies
TJX
$170B
$389M 1.87%
5,122,237
+30,273
+0.6% +$2.1M
TXN icon
15
Texas Instruments
TXN
$260B
$376M 1.8%
1,993,211
-1,446
-0.1% -$278K
CSCO icon
16
Cisco
CSCO
$444B
$357M 1.71%
5,633,978
-677,365
-11% -$38.7M
MDT icon
17
Medtronic
MDT
$105B
$323M 1.55%
3,119,149
-4,332
-0.1% -$502K
DGX icon
18
Quest Diagnostics
DGX
$25.1B
$308M 1.48%
1,778,924
+5,569
+0.3% +$847K
MRK icon
19
Merck
MRK
$322B
$290M 1.39%
3,787,374
+77,162
+2% +$6.15M
LLY icon
20
Eli Lilly
LLY
$1.06T
$274M 1.31%
990,795
-13,334
-1% -$3.38M
V icon
21
Visa
V
$669B
$269M 1.29%
1,243,010
+407,710
+49% +$87.5M
AXP icon
22
American Express
AXP
$233B
$267M 1.28%
1,634,279
-152,251
-9% -$26M
ABT icon
23
Abbott
ABT
$175B
$238M 1.14%
1,688,780
-67,118
-4% -$8.59M
ADBE icon
24
Adobe
ADBE
$84.3B
$204M 0.98%
360,631
-34,432
-9% -$21.5M
OTIS icon
25
Otis Worldwide
OTIS
$27.2B
$204M 0.98%
2,344,640
+30,591
+1% +$2.56M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2021 Portfolio in Review

As of Q4 2021, Grantham, Mayo, Van Otterloo & Co (GMO) held 770 positions worth $20.8B, up 3% from $20.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $923M in Q4 2021, closing 93 positions and reducing 280 holdings. Its most notable exit was VEREIT, Inc., an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in CyrusOne Inc Common Stock worth $58.1M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2021 buy was CyrusOne Inc Common Stock: 647,749 shares worth $58.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to TSMC in Q4 2021, an estimated $125M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $219M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited VEREIT, Inc. in Q4 2021, selling an estimated $121M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 30% of its $20.8B portfolio in Q4 2021.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 97 new positions and closed 93 in Q4 2021.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 3% quarter-over-quarter to $20.8B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2021, filed 11 Feb 2022.